ERIN LAYNE: Open Payments
NPI 1588296453 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 64 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $2,294 · 2025 $1,511
Food & beverage: $1,412Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $248 |
| GENZYME CORPORATION | 9 | $223 |
| ABBVIE INC. | 8 | $201 |
| Novartis Pharmaceuticals Corporation | 6 | $136 |
| UCB, Inc. | 5 | $135 |
| LEO Pharma Inc. | 5 | $112 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $95 |
| Amgen Inc. | 3 | $69 |
| Arcutis Biotherapeutics, Inc. | 3 | $60 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Bimzelx, ADBRY, Sotyktu, OTEZLA, COSENTYX.
Industry payments across VA — which companies pay providers there.
